122 related articles for article (PubMed ID: 38758571)
1. High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
Irvin R; Landry G; Jones MR; James A; Schexnayder J; Rodriguez S; Wendell D; Barthe K; Britton E; LeSar K; Manogue S; Sugarman OK; Brown C; Burgess S; Mehta SH; Thomas DL; Robinson W;
J Viral Hepat; 2024 Jul; 31(7):432-435. PubMed ID: 38758571
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.
Gahrton C; Westman G; Lindahl K; Öhrn F; Dalgard O; Lidman C; Nilsson LH; Said K; Duberg AS; Aleman S
BMC Infect Dis; 2019 Nov; 19(1):955. PubMed ID: 31706284
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
[TBL] [Abstract][Full Text] [Related]
4. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
6. Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.
de la Flor C; Porsa E; Nijhawan AE
Public Health Rep; 2017; 132(6):617-621. PubMed ID: 29045799
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.
Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L
Ann Epidemiol; 2016 Aug; 26(8):570-578.e2. PubMed ID: 27480479
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.
Cieply L; Simmons R; Ijaz S; Kara E; Rodger A; Rosenberg W; McGuinness A; Mbisa JL; Ledesma J; Ohemeng-Kumi N; Dicks S; Potts H; Lattimore S; Mandal S
Epidemiol Infect; 2019 Jan; 147():e145. PubMed ID: 30869036
[TBL] [Abstract][Full Text] [Related]
10. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
[TBL] [Abstract][Full Text] [Related]
11. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.
Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Brixko C; Laukens P; Orlent H; Bilaey P; De Smet F; Hellemans G; Muyldermans G; Van Baelen L; Hens N; Van Vlierberghe H; Robaeys G
BMC Infect Dis; 2021 Jul; 21(1):708. PubMed ID: 34315415
[TBL] [Abstract][Full Text] [Related]
12. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
Johnson A; Shearer J; Thompson C; Jelley R; Aldridge J; Allsop C; Kerry J; Jones D; McCullough F; Miller C; Valappil M; Taha Y; Masson S; Jefferson T; Lawton C; Christensen L; McPherson S
J Viral Hepat; 2023 Dec; 30(12):914-921. PubMed ID: 37700492
[TBL] [Abstract][Full Text] [Related]
13. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
Kileng H; Gutteberg T; Goll R; Paulssen EJ
BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
[TBL] [Abstract][Full Text] [Related]
14. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.
Harris AM; Chokoshvili O; Biddle J; Turashvili K; Japaridze M; Burjanadze I; Tsertsvadze T; Sharvadze L; Karchava M; Talakvadze A; Chakhnashvili K; Demurishvili T; Sabelashvili P; Foster M; Hagan L; Butsashvili M; Morgan J; Averhoff F
BMC Public Health; 2019 May; 19(Suppl 3):466. PubMed ID: 32326938
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
Defante Ferreto LE; Guedes S; Braz Pauli F; Soligo Rovani S; Aní Caovilla Follador F; Paula Vieira A; Himovski Torres R; Colares Coelho H; Welter Wendt G
PLoS One; 2021; 16(7):e0255173. PubMed ID: 34310633
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care.
Abe CM; Aguwa M; Zhao M; Sullivan J; Porsa E; Nijhawan AE
Public Health Rep; 2019; 134(6):626-633. PubMed ID: 31530093
[TBL] [Abstract][Full Text] [Related]
18. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
[TBL] [Abstract][Full Text] [Related]
20. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
